Speakers at CHEST 2026 walked through the first CHEST guideline for non CF adult bronchiectasis, then took up the harder question it leaves open: which preventive therapy to start first.
On the opening day of CHEST 2026 in Phoenix, Arizona, the organization's flagship journal highlights a trio of key papers with practice-changing results.
Selected presentations from “Reframing COPD: Phenotypes, Outcomes, Therapeutics, and the Future of Care Delivery,” a session on the opening day of CHEST 2026.
The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.